KalVista Pharmaceuticals Stock Quote KALV - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

12.45

Bid

12.25

Ask

12.60

Volume

623,294

12.29 Day's Range 12.81

7.30 52 Week Range 15.50

Market Cap

615.254M

Previous Close

12.43

Open

12.50

Last Trade

26974

12.45

(priorref)

Last Trade Time

16:37:51

Financial Volume

$ 7,801,512

VWAP

12.5166

Average Volume (3m)

432,121

Shares Outstanding

49,417,986

Dividend Yield

PE Ratio

-4.85

Earnings Per Share (EPS)

-2.56

Revenue

Net Profit

-126.64M

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angio... KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kalvista.com

Headquarters

Dover, Delaware, USA

Founded

KalVista Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KALV. The last closing price for KalVista Pharmaceuticals was $12.43. Over the last year, KalVista Pharmaceuticals shares have traded in a share price range of $ 7.30 to $ 15.50.

KalVista Pharmaceuticals currently has 49,417,986 shares outstanding. The market capitalization of KalVista Pharmaceuticals is $614.27 million. KalVista Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.85.

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting

–Sebetralstat enabled prompt treatment of laryngeal HAE attacks with median time of 1 hour and 16 minutes to onset of symptom relief– –Pooled...

Form 4 - Statement of changes in beneficial ownership of securities

KalVista Pharmaceuticals to Present at Upcoming Investor Conferences

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the Company will participate in a fireside chat at each of the following...

KalVista Pharmaceuticals to Present New Sebetralstat Data at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that six abstracts have been accepted for presentation at the American Academy of...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.06	9.30640913082	11.39	12.67	11	672800	11.97404709	CS
4	3.04	32.3060573858	9.41	12.67	8.9915	612439	11.01521167	CS
12	3.15	33.8709677419	9.3	12.67	7.3	432121	9.82674728	CS
26	1.72	16.0298229264	10.73	12.85	7.3	420466	10.23232227	CS
52	-0.66	-5.03432494279	13.11	15.5	7.3	380584	11.13641041	CS
156	-2.82	-18.4675834971	15.27	17.06	4.12	359529	10.51536383	CS
260	4.11	49.2805755396	8.34	45	4.12	327469	15.48781289	CS

KALV - Frequently Asked Questions (FAQ)

What is the current KalVista Pharmaceuticals share price?

The current share price of KalVista Pharmaceuticals is $ 12.45

How many KalVista Pharmaceuticals shares are in issue?

KalVista Pharmaceuticals has 49,417,986 shares in issue

What is the market cap of KalVista Pharmaceuticals?

The market capitalisation of KalVista Pharmaceuticals is USD 614.27M

What is the 1 year trading range for KalVista Pharmaceuticals share price?

KalVista Pharmaceuticals has traded in the range of $ 7.30 to $ 15.50 during the past year

What is the PE ratio of KalVista Pharmaceuticals?

The price to earnings ratio of KalVista Pharmaceuticals is -4.85

What is the reporting currency for KalVista Pharmaceuticals?

KalVista Pharmaceuticals reports financial results in USD

What is the latest annual profit for KalVista Pharmaceuticals?

The latest annual profit of KalVista Pharmaceuticals is USD -126.64M

What is the registered address of KalVista Pharmaceuticals?

The registered address for KalVista Pharmaceuticals is 3500 S DUPONT HWY, DOVER, DELAWARE, 19901

What is the KalVista Pharmaceuticals website address?

The website address for KalVista Pharmaceuticals is www.kalvista.com

Which industry sector does KalVista Pharmaceuticals operate in?

KalVista Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DMNDamon Inc	$ 0.2371 (32.68%)	3.48M
SGBXSafe and Green Holdings Corporation	$ 0.705 (29.22%)	6.16M
INTWGraniteShares 2X Long INTC Daily ETF	$ 24.02 (21.01%)	84.28k
SNESSenesTech Inc	$ 2.75 (19.57%)	270.6k
HURATuHURA Biosciences Inc	$ 2.46 (17.14%)	5.82k
CUTRCutera Inc	$ 0.048 (-50.46%)	9.68M
ADTXAditxt Inc	$ 0.0343 (-39.61%)	33.09M
ULYUrgent ly Inc	$ 0.3245 (-36.32%)	374.75k
HEPAHepion Pharmaceuticals Inc	$ 0.04 (-18.03%)	15.12M
CMTLComtech Telecommunications Corporation	$ 1.77 (-16.90%)	261.96k
ADTXAditxt Inc	$ 0.0343 (-39.61%)	33.09M
INTCIntel Corporation	$ 22.89 (10.69%)	19.3M
HEPAHepion Pharmaceuticals Inc	$ 0.04 (-18.03%)	15.12M
BHATBlue Hat Interactive Entertainment Technology	$ 0.0345 (-11.54%)	12.1M
LCIDLucid Group Inc	$ 2.17 (0.46%)	10.69M